Skip to content

Hunter C Smith, Chief Financial Officer at Rhythm Pharmaceuticals, sold RYTM on Aug 31, 2026

Data as of Oct 16

▼ SELL$2.4M23,072 shares at $104.59Hunter C Smith Chief Financial OfficerRYTM Rhythm Pharmaceuticals, Inc.
Watch RYTM
Traded
Aug 31, 2026
Disclosed
Sep 1, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Hunter C Smith, Chief Financial Officer at Rhythm Pharmaceuticals, sold RYTM on Aug 31, 2026TRADEDDISCLOSED
RYTMSimilar stocks (XLV — its sector index fund), rebased to RYTM's price on the disclosure day
RYTM since disclosure
−17.7%
after the sale
Similar stocks (XLV) since disclosure
+2.9%
XLV — its sector index fund

Change in closing price from Sep 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLHunter C Smith Chief Financial OfficerRYTM Rhythm Pharmaceuticals, Inc.$1.2Mdisclosed Sep 1 · filed 1 day after the trade
  2. ▼ SELLHunter C Smith Chief Financial OfficerRYTM Rhythm Pharmaceuticals, Inc.$3Mdisclosed Sep 1 · filed 1 day after the trade

See every trade on RYTM →